HKSH Medical Group Hosts Hong Kong’s First Asia-Oceania Particle Therapy Co-operative Group Conference Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment

(13 November 2025, Hong Kong) Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November 2025. Marking the first-ever landmark particle therapy academic conference in Hong Kong, the PTCOG-AO 2025 Conference attracted close to 600 participants from 16 countries and regions. Leading academic researchers, clinical doctors, medical physicists, and radiation therapy professionals from all over the world, including Mainland China, Japan, Taiwan, South Korea, Singapore, India, Australia, Belgium, the United Kingdom, and the United States shared pioneering research findings, best practices, clinical experiences, and technological innovations, fostering knowledge exchange and collaboration within the industry to explore new possibilities for precision cancer treatment.

Themed “Advancing Particle Therapy with Greater Precision and Image-Guidance”, the three-day PTCOG-AO 2025 Conference commenced on 7 November with the first 2 days held at the Hong Kong Convention and Exhibition Centre, featuring a series of scientific and educational symposia and lectures. The last day was concluded by visits at HKSH Proton Therapy Centre, Hong Kong’s only and the first in the Greater Bay Area. The Conference was bolstered by the immense support of over 60 international, regional and local organisations and exhibitors*, including the Hong Kong Tourism Board and InvestHK, reflecting a strong cross-sector commitment to advancing medical technology.

Please click here for more details.